Veradigm inc. receives approval from nasdaq of plan to regain listing compliance

Chicago--(business wire)-- #healthit--veradigm inc. (nasdaq: mdrx) announced today that nasdaq has accepted the company's plan to regain compliance with nasdaq listing rule 5250(c)(1) and granted the company an exception until september 18, 2023 to file its annual report on form 10-k for the year ended december 31, 2022 (the “form 10-k”) and quarterly report on form 10-q for the quarter ended march 31, 2023 (the “form 10-q”). the company received notice from nasdaq on march 20, 2023, that it was not in com.
MDRX Ratings Summary
MDRX Quant Ranking